Importance of Clinical and Morphological Correlations in Diagnosing Langerhans Cell Histiocytosis

被引:0
作者
Omayma, S. E. B. [1 ]
Fauzana, K. [2 ]
Aisyah, M. R. [3 ]
Noraidah, M. [1 ]
Hamidah, Noor H. [1 ]
机构
[1] Univ Kebangsaan Malaysia, Med Ctr, Dept Pathol, Fac Med, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Hosp Raja Permaisuri Bainun, Dept Pathol, Jalan Raja Ashman, Ipoh 30990, Perak, Malaysia
[3] Hosp Raja Permaisuri Bainun, Dept Pediat, Jalan Raja Ashman, Ipoh 30990, Perak, Malaysia
来源
MEDICINE AND HEALTH-KUALA LUMPUR | 2018年 / 13卷 / 01期
关键词
immunohistochemistry; Langerhans cell histiocytosis; pathology;
D O I
10.17576/MH.2018.1301.21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Langerhans cell histiocytosis (LCH) is a clonal histiocytic disorder. The variable clinical manifestations from isolated bone lesion to multisystem disease can cause difficulties and delay in diagnosis. We report a 2 years and 8 months-old girl who presented with a 2 weeks history of persistent fever and weight loss associated with progressive abdominal distension. Physical examination revealed pallor, bilateral proptosis, seaborrheic dermatitis over the scalp and hepatosplenomegaly. Skull X-ray demonstrated multiple lytic lesions at the base and the skull vault. Bone marrow morphology showed numerous abnormal Langerhans cells (LCs) and foamy macrophages. The trephine immunohistochemistry (IHC) stains for CD1a, S-100 and CD68 were inconclusive. The diagnosis of multisystem Langerhans cell histiocytosis (MS-LCH) in this patient was based on the clinical presentation, radiological and morphological analysis. She subsequently received chemotherapy and currently she is on maintenance therapy with a good clinical response. LCH is a rare disease and although the IHC was inconclusive, the correlation of clinical, radiological and morphological data are essential for the diagnosis.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 12 条
[1]   Langerhans cell histiocytosis: Current concepts and treatments [J].
Abla, Oussama ;
Egeler, R. Maarten ;
Weitzman, Sheila .
CANCER TREATMENT REVIEWS, 2010, 36 (04) :354-359
[2]   How I treat Langerhans cell histiocytosis [J].
Allen, Carl E. ;
Ladisch, Stephan ;
McClain, Kenneth L. .
BLOOD, 2015, 126 (01) :26-35
[3]  
Coleman Mira A, 2013, Open Neuroimag J, V7, P53, DOI 10.2174/1874440001307010053
[4]  
Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO
[5]  
2-C
[6]   Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years [J].
Haupt, Riccardo ;
Minkov, Milen ;
Astigarraga, Itziar ;
Schaefer, Eva ;
Nanduri, Vasanta ;
Jubran, Rima ;
Egeler, R. Maarten ;
Janka, Gritta ;
Micic, Dragan ;
Rodriguez-Galindo, Carlos ;
Van Gool, Stefaan ;
Visser, Johannes ;
Weitzman, Sheila ;
Donadieu, Jean .
PEDIATRIC BLOOD & CANCER, 2013, 60 (02) :175-184
[7]  
JAFFE ES, 1988, SEMIN DIAGN PATHOL, V5, P376
[8]  
Minkov M., 2009, WINDEBANK LANGERHANS
[9]   New Insights Into the Molecular Pathogenesis of Langerhans Cell Histiocytosis [J].
Rizzo, Francesca M. ;
Cives, Mauro ;
Simone, Valeria ;
Silvestris, Franco .
ONCOLOGIST, 2014, 19 (02) :151-163
[10]  
Satter Elizabeth K, 2008, Dermatol Online J, V14, P3